Australian experience with non-adjuvant H1N1 vaccine (Panvax and Panvax Junior)

Australian Prescriber

Volumn 33, Issue 4, 2010, Pages 121-123

  Cook, Jane ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS A H1N1 VACCINE; PANVAX; PANVAX JUNIOR; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ARTICLE; ASTHENIA; AUSTRALIA; CONVULSION; COUGHING; DIARRHEA; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FATIGUE; FEBRILE CONVULSION; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; GUILLAIN BARRE SYNDROME; HEALTH PROGRAM; HUMAN; INFLUENZA A (H1N1); INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE SORENESS; INJECTION SITE SWELLING; LETHARGY; MALAISE; NAUSEA; OROPHARYNGEAL PAIN; PAIN; PATIENT INFORMATION; PRURITUS; RHINORRHEA; URTICARIA; VACCINATION; VOMITING;

EID: 77957026423     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Australian Technical Advisory Group on Immunisation (ATAGI) advice regarding influenza, influenza vaccines and Guillain-Barré Syndrome. Canberra: Australian Government Department of Health and Ageing; 2009. www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/2723D54E78BF5739CA2576400027E1E9/$File/ATAGI-Infl_FluVac_GBS-Advice_091009.pdf [cited 2010 Jul 7]